OpenLegislation

The Private Water Supplies (Wales) Regulations 2010 (revoked)

W.S.I. 2010/66 · Made 13 January 2010 · Extends to England and Wales

Up to date with all changes known to legislation.gov.uk, revised to 20 November 2017.

WATER, WALES

Made 13 January 2010

Laid before the National Assembly for Wales 14 January 2010

Coming into force 4 February 2010

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Regulations revoked (20.11.2017) by The Private Water Supplies (Wales) Regulations 2017 (S.I. 2017/1041), regs. 1, 24(1)(a) (with regs. 3, 26(1)-(3))

[Editorial note: No historical revised versions have been created for amendments to this S.I. made prior to its final revocation. A revised version of how the S.I. stood at its first commencement is available and, to see the document content as it originally stood when it was made, select the 'Original (As Made)' version. For further details of the amendments see the List of All Changes available in 'More Resources']

Contents

  1. Part 1: Water standards Repealed
  2. 1Title, application and commencement Repealed
  3. 2Scope Repealed
  4. 3Exemptions Repealed
  5. 4Wholesomeness Repealed
  6. 5Disinfection Repealed
  7. 6Requirement to carry out a risk assessment Repealed
  8. Part 2: Monitoring Repealed
  9. 7Monitoring Repealed
  10. 8Further distribution of supplies from water undertakers or water supply licensees Repealed
  11. 9Large supplies and supplies to commercial or public premises Repealed
  12. 10Other private supplies Repealed
  13. 10AMonitoring of radioactive substances: general Repealed
  14. 10BMonitoring of radioactive substances: supplies to a single dwelling not used for a commercial or public activity Repealed
  15. 11Sampling and analysis Repealed
  16. 12Maintenance of records Repealed
  17. 13Notification of information Repealed
  18. Part 3: Action in the event of failure Repealed
  19. 14Provision of information Repealed
  20. 15Investigation Repealed
  21. 16Procedure following investigation Repealed
  22. 17Authorisations of different standards Repealed
  23. Part 4: Notice procedure Repealed
  24. 18Notices Repealed
  25. 19Appeals Repealed
  26. 20Penalties Repealed
  27. Part 5: Miscellaneous Repealed
  28. 21Fees Repealed
  29. 22Revocation Repealed
  30. Signature
  31. Schedule 1: Concentrations or Values Repealed
  32. 1Wholesomeness Repealed
  33. 2Indicator Parameters Repealed
  34. 3Radioactive substances parameters Repealed
  35. Schedule 2: Monitoring Repealed
  36. Part 1: Check monitoring Repealed
  37. 1Sampling Repealed
  38. 2Frequency of sampling Repealed
  39. Part 2: Audit monitoring Repealed
  40. 3Sampling Repealed
  41. 4Frequency of sampling Repealed
  42. 3Minimum frequency for both check monitoring and audit monitoring for water put into bottles or containers Repealed
  43. Schedule 2A: Monitoring of radioactive substances Repealed
  44. 1Radon Repealed
  45. 2Tritium Repealed
  46. 3Indicative Dose Repealed
  47. 4Water treatment Repealed
  48. 5Averaging Repealed
  49. Schedule 3: Sampling and analysis Repealed
  50. Part 1: General Repealed
  51. 1Samples: general Repealed
  52. 2Analysing samples Repealed
  53. 3Authorisation of alternative methods of analysis Repealed
  54. 4Sampling and analysis by persons other than local authorities Repealed
  55. Part 2: Analytical methods Repealed
  56. Paragraph Repealed
  57. Paragraph Repealed
  58. Paragraph Repealed
  59. Paragraph Repealed
  60. Paragraph Repealed
  61. Paragraph Repealed
  62. Part 3: Monitoring for indicative dose and analytical performance characteristics Repealed
  63. 5Monitoring for compliance with the indicative dose Repealed
  64. 6Monitoring for compliance with the indicative dose Repealed
  65. 7Screening for certain radionuclides, or screening for an individual radionuclide Repealed
  66. 8Screening for certain radionuclides, or screening for an individual radionuclide Repealed
  67. 9Screening strategies for gross alpha activity and gross beta activity Repealed
  68. 10Screening strategies for gross alpha activity and gross beta activity Repealed
  69. 11Screening strategies for gross alpha activity and gross beta activity Repealed
  70. 12Screening strategies for gross alpha activity and gross beta activity Repealed
  71. 12Calculation of the indicative dose Repealed
  72. 13Calculation of the indicative dose Repealed
  73. 14Performance characteristics and methods of analysis Repealed
  74. Schedule 4: Records Repealed
  75. 1Initial records Repealed
  76. 2Additional records Repealed
  77. Schedule 5: Fees Repealed
  78. 1Fee Repealed
  79. 2Persons liable to pay Repealed
  80. Explanatory note

1Title, application and commencementF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2ScopeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3ExemptionsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4WholesomenessF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5DisinfectionF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6Requirement to carry out a risk assessmentF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7MonitoringF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8Further distribution of supplies from water undertakers or water supply licenseesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9Large supplies and supplies to commercial or public premisesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10Other private suppliesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10AMonitoring of radioactive substances: generalF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10BMonitoring of radioactive substances: supplies to a single dwelling not used for a commercial or public activityF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11Sampling and analysisF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12Maintenance of recordsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13Notification of informationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

14Provision of informationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

15InvestigationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

16Procedure following investigationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

17Authorisations of different standardsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

18NoticesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

19AppealsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

20PenaltiesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

21FeesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22RevocationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1WholesomenessF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2Indicator ParametersF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Radioactive substances parametersF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1SamplingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2Frequency of samplingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3SamplingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Frequency of samplingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Minimum frequency for both check monitoring and audit monitoring for water put into bottles or containersF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1RadonF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2TritiumF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Indicative DoseF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Water treatmentF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5AveragingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1Samples: generalF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2Analysing samplesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Authorisation of alternative methods of analysisF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Sampling and analysis by persons other than local authoritiesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5Monitoring for compliance with the indicative doseF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6Monitoring for compliance with the indicative doseF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7Screening for certain radionuclides, or screening for an individual radionuclideF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8Screening for certain radionuclides, or screening for an individual radionuclideF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9Screening strategies for gross alpha activity and gross beta activityF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10Screening strategies for gross alpha activity and gross beta activityF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11Screening strategies for gross alpha activity and gross beta activityF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12Screening strategies for gross alpha activity and gross beta activityF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12Calculation of the indicative doseF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13Calculation of the indicative doseF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

14Performance characteristics and methods of analysisF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1Initial recordsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2Additional recordsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1FeeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2Persons liable to payF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Explanatory note

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .